Vermillion Inc. Daily Stock Analysis

Daily Stock Analysis, VRML, Vermillion Inc, priceseries

Vermillion Inc. Daily Stock Analysis
Stock Information
Open
3.69
Close
3.55
High
3.70
Low
3.45
Previous Close
3.68
Daily Price Gain
-0.13
YTD High
34.00
YTD High Date
Mar 12, 2010
YTD Low
0.27
YTD Low Date
Dec 27, 2018
YTD Price Change
-22.30
YTD Gain
-86.27%
52 Week High
34.00
52 Week High Date
Mar 12, 2010
52 Week Low
0.27
52 Week Low Date
Dec 27, 2018
52 Week Price Change
-22.30
52 Week Gain
-86.27%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 11. 2017
1.27
Jan 12. 2017
1.33
1 Trading Days
5.12%
Link
LONG
Feb 2. 2017
1.27
Mar 8. 2017
2.32
23 Trading Days
82.98%
Link
LONG
Sep 25. 2017
1.42
Oct 5. 2017
1.60
8 Trading Days
12.42%
Link
LONG
Mar 6. 2019
0.83
Mar 25. 2019
1.26
13 Trading Days
51.63%
Link
LONG
Apr 11. 2019
1.15
Apr 22. 2019
1.22
6 Trading Days
6.30%
Link
LONG
Apr 6. 2020
0.87
Apr 16. 2020
0.93
7 Trading Days
7.29%
Link
LONG
Apr 21. 2020
1.23
Apr 28. 2020
1.30
5 Trading Days
5.89%
Link
LONG
May 14. 2020
2.17
May 21. 2020
2.31
5 Trading Days
6.68%
Link
LONG
May 22. 2020
2.70
Jun 4. 2020
3.33
8 Trading Days
23.25%
Link
LONG
Jun 5. 2020
3.60
Jun 11. 2020
3.82
4 Trading Days
6.18%
Link
Company Information
Stock Symbol
VRML
Exchange
NasdaqCM
Company URL
http://www.vermillion.com
Company Phone
512-519-0400
CEO
Valerie Barber Palmieri
Headquarters
Texas
Business Address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX 78738
Sector
Equity
Industry Category
Drugs
Industry Group
Diagnostic Substances
CIK
0000926617
About

Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. It offers pelvic mass assessment, serum testing, and ovarian mass testing. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Description

Vermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance outcomes for women. It is developing novel diagnostic tests for gynecologic disease with focus on ovarian cancer. The company's lead in vitro diagnostic test is Overa, a blood test to aid physicians in pre-surgical assessment of ovarian tumors for malignancy, using an ialgorithmic approach. It serves clinical reference laboratories, hospital laboratories, and physician offices in the United States. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading